Intermountain Medical Center participated in a trial of the first bioengineered external liver, designed to help acute liver failure patients or are not eligible for or are waiting for a transplant a ...

BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (CDNA) and Miromatrix Medical Inc. (MIRO) -- today announced an exclusive partnership aimed at advancing the ...

SAN DIEGO--(BUSINESS WIRE)-- Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (HUMA) (Nasdaq: HUMA), a commercial-stage biotechnology platform company ...

Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and conduit infection increased initial hospital charges by ...

A phase 1 study of miroliverELAP for the treatment of acute liver failure is currently underway;1 first patient in the study underwent the procedure at Intermountain Medical Center in Murray, Utah ...

An international team of researchers bioengineering human liver tissues uncovered previously unknown networks of genetic-molecular crosstalk that control the organ's developmental processes – greatly ...

Medera’s Novoheart partners with National Heart Centre Singapore (NHCS) to create the world’s first Asian patient-specific miniature human heart model with heart failure, known as “Human ...

Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...

A new method to keep human lymph node tissue alive and functioning outside the body for several days could give researchers a much clearer view of how our immune system responds to infections, ...

- Patients treated with Symvess were observed to have high levels of patency, 100% limb salvage, and zero cases of conduit infection - "Vascular complications of medical or surgical procedures aren't ...